Home › Astrocytoma › California › Baldwin Park
Astrocytoma clinical trials in Baldwin Park, CA
4 studies for Astrocytoma are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Columbus, OH6 studies
- Washington, DC6 studies
- Seattle, WA6 studies
- Durham, NC6 studies
- San Francisco, CA6 studies
- Aurora, CO5 studies
Other studies in Baldwin Park
- Breast Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Colorectal Cancer38 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Metastatic Cancer30 studies
- Myelodysplastic Syndromes26 studies
- Ovarian Cancer25 studies
- Lung Cancer24 studies
- Multiple Myeloma23 studies
- Stomach Cancer22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.